Latest KFF Health News Stories
KHN’s ‘What The Health?’: Waiting For The Trump Health Plan
President Donald Trump keeps promising a new health plan, but so far it’s nowhere to be seen. Meanwhile, Democratic presidential candidate Sen. Bernie Sanders (I-Vt.) is proposing a plan to cancel billions of dollars in medical debt owed by patients. This week, Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss these issues and more. Rovner also interviews KHN’s Rachel Bluth about the latest “Bill of the Month” feature. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
Regreso a clases 2019: mochilas, loncheras y test de drogas
Según expertos, el aumento en las pruebas de drogas es una reacción a la epidemia de opioides y a las leyes de marihuana liberalizadas que se extienden por todo el país.
Back To School 2019: Backpack, Lunchbox And A Drug Test
As schools begin a new year, more districts will test students as young as 11 for illicit drug use even as other drug prevention efforts are scaled back. More than 1 in 3 school districts nationwide give students drug tests.
Americans More Likely Than Swedes To Fill Prescriptions For Opioids After Surgery
New research published in JAMA Network Open quantified for the first time international differences in doctors’ prescribing habits and patients’ use of these highly addictive painkillers.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
In India’s Slums, ‘Painkillers Are Part Of The Daily Routine’
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients’ pain, the nation’s sprawling, cash-fed health care system is ripe for misuse.
Beset By Lawsuits And Criticism In U.S., Opioid Makers Eye New Market In India
What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.
Judge Cites Opioid ‘Menace,’ Awards Oklahoma $572M In Landmark Case
The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Doctors Can Change Opioid Prescribing Habits, But Progress Comes In Small Doses
Research out Wednesday indicates that guidelines are making strides in cutting back the number of pain pills doctors offer after specific types of surgeries.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
KHN’s ‘What The Health?’: Cue The Drug Price Debate
Democrats and Republicans on the Senate Finance Committee unveiled their long-awaited proposal to try to rein in prescription drug costs, even as bipartisan leaders of the other Senate committee that oversees health announced it would not bring its drug price bill to the Senate floor until fall. Paige Winfield Cunningham of The Washington Post, Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this, plus court actions on health issues.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
KHN’s ‘What The Health?’: Biden Doubles Down On Obamacare
Presidential candidate Joe Biden unveiled a health plan intended to provide a more moderate alternative to his competitors’ “Medicare for All” plans. It would build on the Affordable Care Act but would go much further. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss this, plus Planned Parenthood’s very bad week, the U.S. House vote to repeal the health law’s “Cadillac tax” on generous health plans, and the reduction in deaths from opioids.
KHN Investigation On Opioid Prescribers Pains Some Readers And Tweeters
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Pain Meds As Public Nuisance? Oklahoma Tests A Legal Strategy Against Opioid Maker
Oklahoma is seeking $17 billion in damages from Johnson & Johnson, the pharmaceutical giant. After a seven-week trial, a judge will decide if the opioid drugmaker is liable and if so, for how much.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Medicare Going In ‘Right Direction’ On Opioid Epidemic
A new report by the inspector general for HHS shows prescriptions to treat opioid addiction are way up in recent years, while prescriptions for the painkillers have fallen.
Florida es el último estado republicano en adoptar programa de intercambio de jeringas
Un programa piloto en el condado de Miami-Dade demostró la efectividad de esta intervención de salud pública. Una nueva ley podría ampliarla a otros condados.
Florida Is The Latest Republican-Led State To Adopt Clean Needle Exchanges
Florida has struggled for years with opioid overdoses — and the highest rate of HIV infection in the U.S. Lawmakers now hope needle exchanges and a “harm reduction” approach could help save lives.
